0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Sunitinib :

Sunitinib 12.5mg
Sunitinib 25mg
Sunitinib 50mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Sunitinib:

  • Bahamas
  • Belarus
  • Bolivia
  • Cook Islands
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Dominican Republic
  • El Salvador
  • France
  • Germany
  • Gibraltar
  • Guadeloupe
  • India
  • Jamaica
  • Japan
  • Kuwait
  • Malta
  • Morocco
  • Netherlands
  • Netherlands Antilles
  • New Zealand
  • Norway
  • Panama
  • Paraguay
  • Poland
  • Qatar
  • Saint Lucia
  • Serbia
  • Slovakia
  • Spain
  • Sri Lanka
  • Taiwan
  • Trinidad and Tobago
  • Turkey
  • Ukraine
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Sunitinib:

Regorafenib active in metastatic GI stromal tumors - medicalxpress.com

(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, according to a study published ...

A Few Thoughts On The actual Near Future For Doxorubicin - 1UP.COM

TKI to the other, either with sorafenib followed by sunitinib SoSu or sunitinib followed by sorafenib SuSo. Everolimus was associatedwith a median PFS of . months in the in general inhabitants versus . months for placebo hazard ratio HR . self confidence ...

Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC) - Marketwatch

The combination of TORISEL and sunitinib resulted in dose-limiting toxicity (Grade 3/4 erythematous maculopapular rash, and gout/cellulitis requiring hospitalization). For more information on TORISEL, including full prescribing information for ...

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma - News-Medical.Net

after failure of prior treatment with sunitinib or a cytokine. “Despite recent advances in the treatment of advanced kidney cancer, there is a clear need for additional treatment options for patients whose disease has progressed following firs ...

Pfizer's Axitinib Gets Positive Opinion From CHMP - Quick Facts - NASDAQ

after failure of prior treatment with sunitinib or a cytokine. Axitinib, a kinase inhibitor, is an oral therapy that was designed to selectively inhibit tyrosine kinases, including vascular endothelial growth factor receptors 1, 2 and 3 ...

AB SCIENCE : Recruitment of the First Patient for the Phase 3 Study on Gleevec®-Resistant GIST, Comparing Masitinib with Sunitinib - 4-traders (press release)

AB Science SA (Euronext Paris - FR0010557264 - AB)(Paris:AB), a pharmaceutical company specialized in research, development and commercialization of protein kinase inhibitors (PKI), announces today the recruitment of the first patient in a phase 3 study ...

Pfizer announces receipt of positive opinion from the CHMP for marketing authorisation of axitinib in EU - comcast.net

after failure of prior treatment with sunitinib or a cytokine. The company said that axitinib, a kinase inhibitor, is an oral therapy that was designed to selectively inhibit tyrosine kinases, including vascular endothelial growth factor (VEGF) receptors 1 ...

Pfizer does not meet primary endpoint in TORISEL Phase 3 study for advanced RCC - News-Medical.Net

Pfizer Inc. announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL ® (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT ® (sunitinib malate) therapy ...

2 Dow 30 Stocks Enjoying the Bounce - Wall St. Cheat Sheet

The drug is aimed at the treatment of adult patients having advanced renal cell carcinoma, which is a type of advanced kidney cancer, subsequent to failure of prior treatment with sunitinib or a cytokine. The European Commission, which possesses the ...

Pfizer Reports Results From Phase 3 Study Of Torisel - Quick Facts - RTT News

(RTTNews) - Pfizer Inc (PFE: News ) announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL (temsirolimus) in patients with advanced renal cell carcinoma or RCC whose disease had progressed on or after SUTENT (sunitinib malate) therapy ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK